Liberty One Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,373
Closed -$204K 153
2024
Q4
$204K Buy
2,373
+517
+28% +$55.9K 0.02% 136
2024
Q3
$221K Buy
1,856
+3
+0.2% +$400 0.02% 129
2024
Q2
$264K Buy
1,853
+805
+77% +$107K 0.03% 123
2024
Q1
$135K Buy
+1,048
New +$125K 0.02% 148

Other funds holding NVO

Liberty One Investment Management's NVO Position: Q1 2025 in Review

Liberty One Investment Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,373 shares — an estimated $204K sold.

Liberty One Investment Management first reported a position in NVO in Q1 2024 and held it in 4 quarters. The position peaked at $264K in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Liberty One Investment Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Liberty One Investment Management sold 2,373 Novo Nordisk shares in Q1 2025, an estimated $204K.
  • Liberty One Investment Management first reported a position in Novo Nordisk in Q1 2024 and held it in 4 quarters.
  • Liberty One Investment Management's Novo Nordisk position peaked at $264K in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Liberty One Investment Management's 13F filing for Q1 2025, filed 30 Apr 2025.